Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.2.2 Watch group antibiotics |
Outras observações: FIRST CHOICE Community acquired pneumonia (severe) SECOND CHOICE − Pharyngitis Therapeutic alternatives: erythromycin* *as second choice treatment for pharyngitis in children (EMLc only). Clarithromycin is also listed for use in combination regimens for eradication of H. pylori in adults. |
Listas | Seção | Observação |
---|---|---|
Ecuador | Essential Medicines List - Ecuador | Sem observações |
WHO Model List of Essential Medicines (2021) | 6.2.2 Watch group antibiotics |
Outras observações: FIRST CHOICE Community acquired pneumonia (severe) SECOND CHOICE − Pharyngitis Therapeutic alternatives: erythromycin* *as second choice treatment for pharyngitis in children (EMLc only). Clarithromycin is also listed for use in combination regimens for eradication of H. pylori in adults. |
Listas | Seção | Observação |
---|---|---|
Bolivia | LINAME 2011 - 2013 | Sem observações |
Peru | 6.2.2.1 Macrolides and Lincosamides | Sem observações |
Ecuador | Essential Medicines List - Ecuador | Sem observações |
Chile | Essential and Prioritized Medications | Sem observações |
WHO Model List of Essential Medicines (2021) | 6.2.2 Watch group antibiotics |
Outras observações: FIRST CHOICE Community acquired pneumonia (severe) SECOND CHOICE − Pharyngitis Therapeutic alternatives: erythromycin* *as second choice treatment for pharyngitis in children (EMLc only). Clarithromycin is also listed for use in combination regimens for eradication of H. pylori in adults. |
Listas | Seção | Observação |
---|---|---|
Chile | Essential and Prioritized Medications | Sem observações |
Listas | Seção | Observação |
---|---|---|
Cuba | 6.2.4 Macrólidos y lincosamidas | Sem observações |